Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study
BMC Endocrine Disorders · 2026
DOI: 10.1186/s12902-026-02400-0 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BMC Endocrine Disorders, 2026. Verfasst von Sezin Doğan Çakır und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, University of Health Sciences / Prof. Dr. Cemil Tascioglu City Hospital, Kaptan Paşa, Darülaceze Cd. No:2…. Hauptthemen laut MEDLINE: Hypoparathyroidism, Calcium, Endocrinology. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Hypoparathyroidism is a chronic endocrine disorder requiring lifelong management, with real-world data on the impact of follow-up setting on biochemical and clinical outcomes remaining limited. This study aimed to evaluate real-world management of hypoparathyroidism and to investigate whether endocrinology specialist follow-up is associated with improved biochemical control and clinical outcomes. METHODS: This retrospective, single-center study included 186 patients with hypoparathyroidism categorized by follow-up setting (endocrinology vs. non-endocrinology clinics). Demographic, biochemical, and clinical data were collected. The primary outcome was achievement of target serum calcium levels (lower-normal or slightly below-normal range per current guidelines). Multivariate logistic regression was performed to identify independent predictors of target calcium achievement, adjusted for age, sex, eGFR, PTH, treatment doses, and serum 25(OH)D. RESULTS: The mean age of the cohort was 49.5 ± 12.0 years, 78.5% were female and 82.3% had postsurgical hypoparathyroidism. Overall, 76.3% of patients achieved target serum calcium levels; while target phosphate and 25(OH)D levels were achieved in only 45.2% and 46.9%, respectively.Patients followed by endocrinology specialists demonstrated significantly higher rates of target calcium (96.3% vs. 60.6%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, University of Health Sciences / Prof. Dr. Cemil Tascioglu City Hospital, Kaptan Paşa, Darülaceze Cd. No:27, İstanbu, Şişli, 34384, Türkiye. sezin.dogan@gmail.com.
- Department of Endocrinology and Metabolism, University of Health Sciences / Prof. Dr. Cemil Tascioglu City Hospital, Kaptan Paşa, Darülaceze Cd. No:27, İstanbu, Şişli, 34384, Türkiye.
Zitieren
APA
Doğan Çakır, S., & Adaş, M. (2026). Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02400-0
Vancouver
Doğan Çakır S, Adaş M. Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study. BMC Endocrine Disorders. 2026. doi:10.1186/s12902-026-02400-0
BibTeX
@article{Doanakr2026,
author = {Doğan Çakır, Sezin and Adaş, Mine},
title = {Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study},
journal = {BMC Endocrine Disorders},
year = {2026},
doi = {10.1186/s12902-026-02400-0}
}
EUVIMED